Effect of gemfibrozil on intermediate-density lipoproteins in NIDDM patients. A retrospective study.
Bell
D S
DS
Wagenknecht
L E
LE
D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications; D015248:Gemfibrozil / Q000627:therapeutic use*; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D008074:Lipoproteins / Q000097:blood*; D053419:Lipoproteins, IDL; D012189:Retrospective Studies
D008074:Lipoproteins; D053419:Lipoproteins, IDL; D015248:Gemfibrozil